<b>Excellent news.</b><br>- - -<br><br><div class="gmail_quote">On Sun, Feb 26, 2012 at 22:37, ari <span dir="ltr"><<a href="mailto:sultane@yahoo.com" target="_blank">sultane@yahoo.com</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">


<table border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="font:inherit" valign="top"><div></div></td></tr></tbody></table>            <div>
                <div>
                    <br>
                    <div style="font-family:times new roman,new york,times,serif;font-size:12pt">
                        <font face="Tahoma">
                            <hr size="1">
                            <b>
                                <span style="font-weight:bold">From:</span>
                            </b>
                            Intellectual Property Watch <<a href="mailto:noreply@ip-watch.ch" target="_blank">noreply@ip-watch.ch</a>>;                            <br>
                            <b>
                                <span>To:</span>
                            </b>
                             <<a href="mailto:sultane@yahoo.com" target="_blank">sultane@yahoo.com</a>>;                                                                                                     <br>
                            <b>
                                <span>Subject:</span>
                            </b>
                            IP-Watch Brief: US, WIPO IP Summit In Africa Postponed                            <br>
                            <b>
                                <span style="font-weight:bold">Sent:</span>
                            </b>
                            Sun, Feb 26, 2012 7:28:31 PM                            <br>
                            </font>
                            <br>
                            <table border="0" cellpadding="0" cellspacing="0">
                                <tbody>
                                    <tr>
                                        <td style="font:inherit" valign="top">This is the post digest for <a rel="nofollow">sultane@yahoo.com</a> sent by the Intellectual Property Watch website.<br><br>******************************<br>

February 26, 2012. US, WIPO IP Summit In Africa Postponed<br><br>A training programme on intellectual property organised by the United States with several partners to be held in Africa in April has been postponed under pressure to make the programme more transparent and representative of all stakeholders. <br>


<br>Link to the article: <a rel="nofollow" href="http://www.ip-watch.org/?p=19700&utm_source=post&utm_medium=email&utm_campaign=alerts" target="_blank">http://www.ip-watch.org/?p=19700&utm_source=post&utm_medium=email&utm_campaign=alerts</a><br>


<br></td></tr></tbody></table></div></div></div></blockquote></div>- - -<br><br>A rather long but informative article:<br><br><a href="http://www.ip-watch.org/2012/02/12/us-wipo-training-programme-on-ip-rights-in-africa-comes-under-fire/">http://www.ip-watch.org/2012/02/12/us-wipo-training-programme-on-ip-rights-in-africa-comes-under-fire/</a><br>

<br>an excerpt ..<br><br>Prof. Brook Baker of Northeastern University law school and Health GAP, said: It is deeply problematic that the Obama administration continues to pursue efforts to strengthen, widen, and lengthen patent, data, and copyright monopolies in African countries that desperately need expanded access to medicines, educational materials, and climate control technologies and that it simultaneously seeks even stronger enforcement of IP protections than what is currently required under international law. Carrying the policy portfolio of Big Pharma and other IP-based multinationals under the guise of addressing Africa’s needs, the proposed African IP Summit is a chilling example of US duplicity and conflict of interest at its worst. However, it is equally problematic if Africa leaders and policy makers, some of whom are already complicit with the US agenda, continue to drink the IP KoolAid as they’ve done with proposed anti-counterfeiting legislation and with their long-lasting lethargy in amending their IP laws to take full advantage of TRIPS flexibilities and thereafter to use those flexibilities to access medicines and other essential technologies.”<br>

<br><br>